Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 1606474)

1.

Increased Amplitude of Low Frequency Fluctuations but Normal Hippocampal-Default Mode Network Connectivity in Schizophrenia.

McHugo M, Rogers BP, Talati P, Woodward ND, Heckers S.

Front Psychiatry. 2015 Jun 24;6:92. doi: 10.3389/fpsyt.2015.00092. eCollection 2015.

2.

Increased hippocampal blood volume and normal blood flow in schizophrenia.

Talati P, Rane S, Skinner J, Gore J, Heckers S.

Psychiatry Res. 2015 Jun 30;232(3):219-25. doi: 10.1016/j.pscychresns.2015.03.007. Epub 2015 Apr 3.

PMID:
25896442
3.

Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.

Aguilar DD, Chen L, Lodge DJ.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu035. doi: 10.1093/ijnp/pyu035.

4.

GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.

Heckers S, Konradi C.

Schizophr Res. 2014 Oct 18. pii: S0920-9964(14)00533-7. doi: 10.1016/j.schres.2014.09.041. [Epub ahead of print] Review.

PMID:
25449711
5.

Isolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability.

Small SA.

Neuron. 2014 Oct 1;84(1):32-9. doi: 10.1016/j.neuron.2014.08.030. Review.

PMID:
25277453
6.

Increased hippocampal CA1 cerebral blood volume in schizophrenia.

Talati P, Rane S, Kose S, Blackford JU, Gore J, Donahue MJ, Heckers S.

Neuroimage Clin. 2014 Jul 22;5:359-64. doi: 10.1016/j.nicl.2014.07.004. eCollection 2014.

7.
8.

Neuroimaging biomarkers for early drug development in schizophrenia.

Tregellas JR.

Biol Psychiatry. 2014 Jul 15;76(2):111-9. doi: 10.1016/j.biopsych.2013.08.025. Epub 2013 Oct 4. Review.

9.

The effect of distracting noise on the neuronal mechanisms of attention in schizophrenia.

Tregellas JR, Smucny J, Eichman L, Rojas DC.

Schizophr Res. 2012 Dec;142(1-3):230-6. doi: 10.1016/j.schres.2012.09.008. Epub 2012 Oct 9.

10.

Neuroimaging of frontal-limbic dysfunction in schizophrenia and epilepsy-related psychosis: toward a convergent neurobiology.

Butler T, Weisholtz D, Isenberg N, Harding E, Epstein J, Stern E, Silbersweig D.

Epilepsy Behav. 2012 Feb;23(2):113-22. doi: 10.1016/j.yebeh.2011.11.004. Epub 2011 Dec 29. Review.

11.

Neural models of schizophrenia.

Heckers S.

Dialogues Clin Neurosci. 2000 Sep;2(3):267-79.

12.

A pathophysiological framework of hippocampal dysfunction in ageing and disease.

Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA.

Nat Rev Neurosci. 2011 Sep 7;12(10):585-601. doi: 10.1038/nrn3085. Review.

13.

Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.

Drew LJ, Stark KL, FĂ©nelon K, Karayiorgou M, Macdermott AB, Gogos JA.

Mol Cell Neurosci. 2011 Aug;47(4):293-305. doi: 10.1016/j.mcn.2011.05.008. Epub 2011 May 24.

14.

Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.

Thompson Ray M, Weickert CS, Wyatt E, Webster MJ.

J Psychiatry Neurosci. 2011 May;36(3):195-203. doi: 10.1503/jpn.100048.

15.

How high-resolution basal-state functional imaging can guide the development of new pharmacotherapies for schizophrenia.

Gaisler-Salomon I, Schobel SA, Small SA, Rayport S.

Schizophr Bull. 2009 Nov;35(6):1037-44. doi: 10.1093/schbul/sbp114. Epub 2009 Oct 14.

16.

Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.

Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T, Malaspina D, Small SA.

Arch Gen Psychiatry. 2009 Sep;66(9):938-46. doi: 10.1001/archgenpsychiatry.2009.115.

17.

Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring.

Stephan KE, Friston KJ, Frith CD.

Schizophr Bull. 2009 May;35(3):509-27. doi: 10.1093/schbul/sbn176. Epub 2009 Jan 20. Review.

18.

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA.

Trends Neurosci. 2008 May;31(5):234-42. doi: 10.1016/j.tins.2008.02.005. Epub 2008 Apr 7. Review.

19.

Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia.

Whalley HC, Gountouna VE, Hall J, McIntosh A, Whyte MC, Simonotto E, Job DE, Owens DG, Johnstone EC, Lawrie SM.

BMC Psychiatry. 2007 Oct 29;7:61.

20.

Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism.

Ragland JD, Yoon J, Minzenberg MJ, Carter CS.

Int Rev Psychiatry. 2007 Aug;19(4):417-27. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk